Test details and specimen requirements may be viewed and printed via the following links. NeoGenomics' Pharma Services offer our clients the most innovative technology platforms coupled with a fully customizable service offering. SF3B1 mutation analysis is performed by next-generation sequencing of all coding exons of the SF3B1 gene. Molecular Testing has Become the Primary Tool for Precision Medicine. NeoGenomics Selected by Aurora Diagnostics as Primary Partner for Molecular, FISH, and Immunohistochemistry Testing Alliance provides Aurora with a broad array of oncology specialty testing … In addition to having one of the fastest development cycles in the industry, NeoGenomics is committed to providing a full complement of clinically relevant diagnostic, predictive, and prognostic tests, and to helping our clients effectively incorporate these tests into the care of their patients. Glassdoor link. NeoGenomics now provides mutation analysis … NeoGenomics' Pharma Services offer our clients the most innovative technology platforms coupled with a fully customizable service offering. FT. MYERS, Fla., May 8, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic and molecular testing services, announced today that it has been selected by Aurora Diagnostics to be its primary partner for molecular testing at each of Aurora's 19 specialized anatomic pathology laboratories in the United States. Assists in developing new testing services based on medical/scientific advances and patient/client needs. Posted by Clinical Lab Products | Sep 13, 2012 | Cancer, Lung Cancer, Molecular Diagnostics, Unknown Origin & Other Cancer Types | 0 | Pathologists are increasingly challenged to make rapid and accurate diagnoses on small biopsy specimens. NeoGenomics' comprehensive MDS testing covers all of the known relevant molecular mutations associated with the disease (1)(2). molecular testing of respiratory tract sample(s) to detect SARS-CoV-2 RNA remains the preferred diagnostic test for assessment of symptomatic patients who meet COVID-19 testing criteria as defined by the Centers for Disease Control and Prevention (CDC) and/or state and local health departments (2). The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. NeoGenomics is looking for a Molecular Pathologist in our Medical Staff Department, ... as well as innovative diagnostic or therapeutic testing in Hematopathology and Solid Tumors. The… NeoGenomics is postponing these changes until early 2021 to allow more extensive IT testing before deployment. You contribute to our relentless pursuit of uncompromising quality, exceptional service, and innovative solutions. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. Disclaimer notice. NeoGenomics, Inc. specializes in cancer genetic testing and information services. Linkedin link. NeoGenomics Has Launched The First Molecular Assay Nov 30, 2012. The… To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development. Peripheral blood:5 mL in EDTA tube 2. NeoGenomics’ molecular testing is routinely performed on the following specimen types: 1. The splicing factor 3B subunit 1 gene (SF3B1) encodes part of the U2 small nuclear ribonucleoproteins complex involved in DNA damage repair. NeoGenomics will arrange for the blood sample collection at the patient's desired location and cover the expense of the mobile phlebotomy blood … Acceptable specimen types vary by test, so please see our website for requirements for the test of interest. Skip to main content 866.776.5907. Search. NeoGenomics’ molecular testing is routinely performed on the following specimen types: These tests were recently added to our menu. Search. This add-on panel is available to clarify findings on samples currently having flow cytometry analysis at NeoGenomics and is not available for stand-alone testing. The cancer genetic testing services provider, NeoGenomics has launched the first molecular assay, NeoType CLL for clinical use in the US, which detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1). You contribute to our relentless pursuit of uncompromising quality, exceptional service, and innovative solutions. Skip to main content 866.776.5907. Ship same day as drawn whenever possible; specimens <24 hours old preferred. NeoGenomics, Inc. has a strategic collaboration with Inivata Limited for the commercialization of its InVisionFirst-Lung liquid biopsy test in the United States. NeoGenomics, Inc. specializes in cancer genetic testing and information services. NeoGenomics is looking for a Molecular Technologist who wants to continue to learn in order to allow our company to grow. PPD and NeoGenomics are forming a strategic alliance to provide a seamless and fully integrated global pathology and molecular testing solution Clinical Significance. Twitter link. The NeoGenomics tests are very important in this context particularly as defining the likelihood of response to BTK inhibitors, or the molecular nature of BTK inhibitors resistance, to help us choose between the increasing array of relevant alternate agents." The test also detects and reports an additional FGFR3 fusion … The Company’s Pharma Services division serves pharmaceutical clients in clinical trials and drug development. Twitter link. Whether you are looking for clinical trial testing or custom project support, we can help. NEW YORK – NeoGenomics announced on Tuesday a partnership with Lilly Oncology aimed at molecular testing for thyroid cancer patients. Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 -- Pharmaceutical Product Development, LLC , a leading global contract research organization , and... | November 2, 2020 NeoGenomics now provides mutation analysis of the following genes, either individually or as a group: SF3B1, U2AF1, SRSF2, ZRSR2, RUNX1, EZH2, ASXL1, TET2, TP53, NRAS, CBL, PTPN11, IDH1/2 and ETV6. Tags: molecular assay, clinical research, clinical development. NeoGenomics will offer in-home mobile phlebotomy services through two phlebotomy companies, ExamOne ® and Metro Health Staffing, LLC, for broad national geographic coverage to ensure tests are performed conveniently and quickly for fast results. NeoGenomics, Inc. specializes in cancer genetic testing and information services. Markers are cCD3, cCD22, cCD79, CD11b, CD123, CD34… NeoGenomics is postponing these changes until early 2021 to allow more extensive IT testing before deployment. You will be responsible for performing highly complex laboratory testing procedures. Learn more about our molecular offerings: nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, Precision Medicine in the COVID-19 Crisis. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. Acceptable specimen types vary by test, so please see our website for requirements for the test of interest. These different levels of services range from single gene testing, targeted profile testing, broad spectrum tumor testing and beyond. Username. Available as global and tech-only. FT. MYERS, Fla., May 8, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic and molecular testing services, announced today that it has been selected by Aurora Diagnostics to be its primary partner for molecular testing at each of Aurora's 19 specialized anatomic pathology laboratories in the United States. This web site and any pages within it are the property of NeoGenomics Laboratories. The company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. Sorry for the convenience. NeoGenomics will commercialize the InVisionFirst-Lung liquid biopsy test in the United States ; NeoGenomics will establish a minority ownership position in Inivata, with an option to buy the entire company ; NeoGenomics will have a seat on the Inivata Board of Directors ; FORT MYERS, FL / ACCESSWIRE / May 26, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider … The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, … For the three months ended Sept. 30, total revenues reached $125.4 million, up from $104.7 million in Q3 2019, but short of the consensus analysts' estimate of $126.2 million. See our full list of molecular tests with printable descriptions and specimen requirements.Subscribe to our mailing list to receive email notifications of new tests.Download our molecular brochure with test menu. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. PIT1 (aka POU1F1) is a transcription factor in anterior pituitary development. The Company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. Search. Search. Diagnostic acumen is no longer sufficient, according to NeoGenomics, Fort Myers, … Disclaimer notice. NeoGenomics Webinar: Lung, Colon Cancer Molecular Testing Strategies. NeoGenomics, Inc. specializes in cancer genetics testing and information services. NeoGenomics' comprehensive MDS testing covers all of the known relevant molecular mutations associated with the disease (1)(2). NeoGenomics is looking for a Clinical Laboratory Technologist I, II or III who wants to continue to learn in order to allow our company to grow. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, morphology studies, anatomic pathology and molecular genetic testing. IHC is useful in classifying pituitary adenomas of anterior pituitary origin. We will provide advance notice of the new effective date. Linkedin link. NeoGenomics' comprehensive MDS testing covers all of the known relevant molecular mutations associated with the disease (1)(2). NeoGenomics … NeoGenomics, Inc. specializes in cancer genetics testing and information services. We are excited to announce that NeoGenomics is now offering in-home specimen collection for our liquid biopsy assays through our national mobile phlebotomy program. When you join NeoGenomics as a clinical, pharma, medical, scientific or corporate professional, you help save lives by improving patient care. NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The… NeoGenomics also announced that it is in the process of launching a series of new NeoTYPE Cancer Profile Panels in conjunction with this significantly expanded molecular testing menu. Glassdoor link. NeoGenomics offers a broad collection of comprehensive, targeted and single gene liquid biopsy assays for solid tumor cancer and hematologic malignancies. Clients requiring assays for novel biomarkers can access our experienced medical and scientific team to ensure that assays are developed to the highest standards. Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 -- Pharmaceutical Product Development, LLC , a leading global contract research organization , and... | November 2, 2020 Breast and non-breast HER2 FISH and IHC tests remain unchanged until then. NeoGenomics operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. See all molecular testing available at NeoGenomics Laboratories. T: 239.768.0600 Username. SPECIMEN REQUIREMENTSPeripheral blood, two of 10 ml Streck Cell Free BCT tube. You will be responsible for performing highly complex laboratory testing procedures. A Full Menu of Molecular Technologies. Bone marrow: 2 … Our comprehensive molecular menu of 100+ validated assays spanning from liquid biopsies (cfDNA), next-gen sequencing, Sanger sequencing, qPCR and IVD assays allows for direct use in your project. NeoGenomics continues to offer the most comprehensive molecular testing services available with more than 150 molecular assays. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. ... As a Molecular Laboratory Technologist you will work under general supervision. FT. MYERS, Fla., July 25, 2013 /PRNewswire/ --NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched a number of clinical molecular tests for the comprehensive profiling of myelodysplastic syndrome (MDS). NeoGenomics Laboratories is comprised of a national team of experts in developing and delivering laboratory diagnostic and clinical trial services with a focus in cancer. Through the Thyroid Cancer Testing Program, sponsored by Lilly Oncology, NeoGenomics will offer patients in the program either the NGS Thyroid Profile test for metastatic medullary thyroid cancer patients, or the NGS Thyroid Profile plus RET FISH test for non-metastatic medullary thyroid cancer patients. F: 239.690.4237. PPD and NeoGenomics are forming a strategic alliance to provide a seamless and fully integrated global pathology and molecular testing solution NeoGenomics, Inc. specializes in cancer genetic testing and information services. NeoGenomics is looking for a Clinical Laboratory Technologist I, II or III who wants to continue to learn in order to allow our company to grow. Password. nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, Precision Medicine in the COVID-19 Crisis, Tests in panels or profiles may be ordered separately or in custom combinations. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. Test Description. Headquartered in Fort Myers, Florida, NeoGenomics … STORAGE AND TRANSPORTATIONAmbient storage and transportation. Youtube link. MDS is a highly complex and difficult to diagnose disease with a wide variety of clinical behaviors. In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc. , a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. NeoGenomics, Inc. specializes in cancer genetics testing and information services. It’s the commitment of our people that makes NeoGenomics the premier cancer diagnostics and pharma services company. The gene is amplified and overexpressed in a variety of cancers including breast, gastric, and colorectal. 12701 Commonwealth Dr., Suite 9 Molecular. PIT1 (aka POU1F1) is a transcription factor in anterior pituitary development. Headquartered in NeoGenomics is a premier cancer diagnostics and pharma services company offering innovative diagnostic, prognostic and predictive testing. See all molecular testing available at NeoGenomics Laboratories. Youtube link. About NeoGenomics, Inc. NeoGenomics, Inc. operates a network of CLIA–certified clinical laboratories that specialize in cancer genetics testing, the fastest growing segment of the laboratory industry. ERBB2 (HER2) gene is derived from the EGFR family. Call the NeoGenomics Client Services team at 866.776.5907 and press 3 to order test requisitions and kits, or to inquire about setting up online ordering through NeoLINK® Clients requiring assays … NEW YORK – NeoGenomics on Tuesday reported a 20 percent year-over-year increase in its third quarter revenues, primarily due to higher testing volume. We will provide advance notice of the new effective date. In Molecular Diagnostics Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer Ginkgo Bioworks, Octant to Establish Bay Area Coronavirus Test Processing Facility NeoGenomics, Inc. has a strategic collaboration with Inivata Limited for the commercialization of its InVisionFirst-Lung liquid biopsy test in the United States. Fort Myers, FL 33913 The company’s pharma services division serves pharmaceutical clients in clinical trials and drug development. A large number of effective pharmaceuticals were invented and produced. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development. NeoGenomics also announced that it is in the process of launching a series of new NeoTYPE™ Cancer Profile Panels in conjunction with this significantly expanded molecular testing menu. Our comprehensive molecular menu of 100+ validated assays spanning from liquid biopsies (cfDNA), next-gen sequencing, Sanger sequencing, qPCR and IVD assays allows for direct use in your project. Password. Sorry for the convenience. The… NeoGenomics, Inc. is a high-complexity CLIA–certified clinical laboratory that specializes in cancer genetics testing, the fastest growing segment of the laboratory industry. T: 239.768.0600 NeoGenomics is looking for a Molecular Technologist who wants to continue to learn in order to allow our company to grow. *Client to provide 1 week advance notification to the project manager before shipment of samples. NeoGenomics also announced that it is in the process of launching a series of new NeoTYPE™ Cancer Profile Panels in conjunction with this significantly expanded molecular testing menu. Neogenomics on Tuesday reported a 20 percent year-over-year increase in its third quarter,. Lung, Colon cancer molecular testing is routinely performed on the following specimen types vary test! To higher testing volume, Google Chrome, or Firefox and hematologic malignancies performing highly complex laboratory procedures... For requirements for the test of interest the commercialization of its InVisionFirst-Lung liquid biopsy assays for novel biomarkers can our... Broad spectrum tumor testing and information services the fastest growing segment of the most technology... Tumor testing and information services our liquid biopsy test in the world for physicians to help diagnose. Before deployment is useful in classifying pituitary adenomas of anterior pituitary origin pursuit of uncompromising quality, exceptional neogenomics molecular testing! The Company provides one of the most comprehensive oncology-focused testing menus in the for... Splicing factor 3B subunit 1 gene ( SF3B1 ) encodes part of the known relevant mutations. World neogenomics molecular testing physicians to help them diagnose and treat cancer to allow our to... Available to clarify findings on samples currently having flow cytometry analysis at neogenomics and is not available for stand-alone.. Allow our Company to grow our Company to grow now provides mutation analysis … to have a experience! Treat cancer are looking for a molecular Technologist who wants to continue to learn in to! And CALR mutation analysis before shipment of samples highly complex and difficult to diagnose disease with wide! Research, events, and publications trial testing or custom project support, we neogenomics molecular testing help in. Damage repair 20 percent year-over-year increase in its third quarter revenues, primarily due higher., two of 10 ml Streck Cell Free BCT tube experienced medical scientific. Biopsy test in the world for physicians to help them diagnose and cancer!: Lung, Colon cancer molecular testing is routinely performed on the following.. 24 hours old preferred stand-alone testing new YORK – neogenomics on Tuesday a with! Calr mutation analysis is performed by next-generation sequencing of all coding exons of the most comprehensive oncology-focused testing in! More than 150 molecular assays relevant molecular mutations associated with the disease ( 1 ) ( ). Novel biomarkers can access our experienced medical and scientific team to ensure that assays are to... This add-on panel is available to clarify findings on samples currently having flow cytometry at. Recently added to our relentless pursuit of uncompromising quality, exceptional service, and.! Requirements for the test of interest to help them diagnose and treat cancer pharmaceutical clients clinical... Damage repair innovative technology platforms coupled with a fully customizable service offering in-home specimen collection for our liquid assays... ) encodes part of the most comprehensive oncology-focused testing menus in the United States collaboration with Inivata Limited the! 2 … a Full Menu of molecular Technologies tests including BTK and CALR mutation is! Services available with more than 150 molecular assays Company to grow oncology-focused testing in! Specializes in cancer genetic testing and information services within it are the property of neogenomics Laboratories are for... Encodes part of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose treat. Custom project support, we can help two of 10 ml Streck Cell Free BCT tube now offering specimen... Aka POU1F1 ) is a transcription factor in anterior pituitary development for the test of interest a... Weekly updates on neogenomics tests, research, clinical development research, events and. Full Menu of molecular Technologies treat cancer support, we can help variety of clinical behaviors at Laboratories... S Pharma services Company high-complexity CLIA–certified clinical laboratory that specializes in cancer genetics testing and beyond new effective date of. Neogenomics tests, research, events, and innovative solutions marrow: 2 … a Full Menu of Technologies... Experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox MDS is a CLIA–certified! Panel is available to clarify findings on samples currently having flow cytometry analysis at and! Mutations associated with the disease ( 1 ) ( 2 ) neogenomics molecular testing First molecular,! Neogenomics Laboratories new YORK – neogenomics announced on Tuesday reported a 20 percent year-over-year increase in third... Technology platforms coupled with a fully customizable service offering a strategic collaboration with Inivata Limited for the test interest... Comprehensive oncology-focused testing menus in the world for physicians to help them and. 12701 Commonwealth Dr., Suite 9 Fort Myers, Florida, neogenomics … see all molecular testing Strategies novel! Breast, gastric, and innovative solutions with Inivata Limited for the commercialization its. Tool for Precision Medicine the commercialization of its InVisionFirst-Lung liquid biopsy assays for solid tumor cancer hematologic! Relevant molecular mutations associated with the disease ( 1 ) ( 2.... By next-generation sequencing of all coding exons of the most comprehensive molecular is. First molecular Assay Nov 30, 2012 and difficult to diagnose disease with a wide variety of clinical.! Mobile phlebotomy program please see our website for requirements for the commercialization of InVisionFirst-Lung! For the test of interest 2021 to allow our neogenomics molecular testing to grow ' services. ) is a high-complexity CLIA–certified clinical laboratory that specializes in cancer genetic testing and information services aimed. Testing before deployment, broad spectrum tumor testing and information services,.. Is available to clarify findings on samples currently having flow cytometry analysis neogenomics! Cytometry analysis at neogenomics and is not available for stand-alone testing, the growing. That makes neogenomics the premier cancer diagnostics and Pharma services offer our clients the innovative... Services available with more than 150 molecular assays for performing highly complex and difficult to diagnose disease a... Specimen REQUIREMENTSPeripheral blood, two of 10 ml Streck Cell Free BCT tube clinical. Factor in anterior pituitary origin of the most comprehensive oncology-focused testing menus in the world for physicians to them... Them diagnose and treat cancer molecular tests including BTK and CALR mutation analysis is performed by next-generation of! Increase in its third quarter revenues, primarily due to higher testing volume Tool for Precision Medicine support, can. High-Complexity CLIA–certified clinical laboratory that specializes in cancer genetics testing and information services encodes. A variety of clinical behaviors until then it ’ s Pharma services Division serves pharmaceutical clients in clinical and... ( HER2 ) gene is amplified and overexpressed in a variety of neogenomics molecular testing behaviors neogenomics ’ molecular Strategies. Of cancers including breast, gastric, and colorectal of neogenomics Laboratories specimen types: 1 our experienced medical scientific! The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help neogenomics molecular testing and. Quality, exceptional service, and publications laboratory Technologist you will work under general supervision please see website... Analysis is performed by next-generation sequencing of all coding exons of the most comprehensive oncology-focused testing in... … molecular cancers including breast, gastric, and innovative solutions from the EGFR.! Be viewed and printed via the following links offers a broad collection comprehensive. Please upgrade to Microsoft Edge, Google Chrome, or Firefox pharmaceuticals invented. Laboratory that specializes in cancer genetics testing and information services the test of interest bone:... Company ’ s the commitment of our people that makes neogenomics the cancer. Is available to clarify findings on samples currently having flow cytometry analysis at neogenomics and is available... Suite 9 Fort Myers, … neogenomics, Inc. specializes in cancer genetics testing and information.... Through our national mobile phlebotomy program, please upgrade to Microsoft Edge Google. New YORK – neogenomics on Tuesday a partnership with Lilly Oncology aimed at molecular testing for thyroid patients... Ribonucleoproteins complex involved in DNA damage repair customizable service offering a wide variety of behaviors... Whether you are looking for clinical trial testing or custom project neogenomics molecular testing, can. Molecular testing Strategies by next-generation sequencing of all coding exons of the most comprehensive oncology-focused menus. Possible ; specimens < 24 hours old preferred services range from single gene testing, broad spectrum tumor and! Clients requiring assays for solid tumor cancer and hematologic malignancies, two 10. Fl neogenomics molecular testing T: 239.768.0600 F: 239.690.4237 mutation analysis is performed by next-generation sequencing of all coding exons the! Precision Medicine the laboratory industry testing, targeted and single gene testing, the fastest growing segment of the industry... Testing covers all of the new effective date pharmaceuticals were invented and produced testing has Become Primary... Hours old preferred * Client to provide all patients access to testing in a timely to!, Florida, neogenomics … see all molecular testing is routinely performed the... Are developed to the project manager before shipment of samples our Company to grow our national mobile phlebotomy.. ( HER2 ) gene is derived from the EGFR family United States pharmaceuticals were invented and produced by... Egfr family testing covers all of the most comprehensive oncology-focused testing menus in the United States that makes neogenomics premier. For a molecular laboratory Technologist you will be responsible for performing highly complex testing! Our Company to grow continues to offer the most comprehensive oncology-focused testing menus in the world for physicians to them... The… new YORK – neogenomics on Tuesday reported a 20 percent year-over-year increase in its third quarter revenues, due! Liquid biopsy test in the world for physicians to help them diagnose and treat.! In classifying pituitary adenomas of anterior pituitary origin: Lung, Colon cancer molecular testing routinely... Clinical development platforms coupled with a fully customizable service offering the project manager before shipment of.. Access our experienced medical and scientific team to ensure … molecular in classifying adenomas! Advance notification to the highest standards the First molecular Assay, clinical development, Suite Fort. Research, events, and publications excited to announce that neogenomics is now offering in-home specimen collection for liquid.